DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 894 filers reported holding DANAHER CORPORATION in Q1 2014. The put-call ratio across all filers is 0.37 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,763,491 | -2.5% | 15,063 | -2.6% | 0.03% | -6.7% |
Q1 2024 | $3,860,671 | +2.9% | 15,460 | -4.7% | 0.03% | -3.2% |
Q4 2023 | $3,753,492 | -12.0% | 16,225 | -5.7% | 0.03% | -18.4% |
Q3 2023 | $4,266,824 | +8.2% | 17,198 | +4.7% | 0.04% | +18.8% |
Q2 2023 | $3,943,200 | -14.9% | 16,430 | -10.7% | 0.03% | -17.9% |
Q1 2023 | $4,636,024 | -4.3% | 18,394 | +0.8% | 0.04% | -7.1% |
Q4 2022 | $4,845,508 | +4.0% | 18,256 | +1.2% | 0.04% | -2.3% |
Q3 2022 | $4,660,000 | -3.9% | 18,042 | -5.7% | 0.04% | +2.4% |
Q2 2022 | $4,851,000 | -12.4% | 19,133 | +1.3% | 0.04% | +7.7% |
Q1 2022 | $5,539,000 | -13.5% | 18,883 | -2.9% | 0.04% | +8.3% |
Q4 2021 | $6,401,000 | +8.3% | 19,456 | +0.2% | 0.04% | +2.9% |
Q3 2021 | $5,909,000 | +11.1% | 19,410 | -2.1% | 0.04% | +12.9% |
Q2 2021 | $5,318,000 | +26.5% | 19,817 | +6.1% | 0.03% | +14.8% |
Q1 2021 | $4,204,000 | -7.4% | 18,676 | -8.7% | 0.03% | -10.0% |
Q4 2020 | $4,542,000 | +6.1% | 20,448 | +2.9% | 0.03% | -3.2% |
Q3 2020 | $4,281,000 | +21.1% | 19,879 | -0.6% | 0.03% | +14.8% |
Q2 2020 | $3,536,000 | +29.2% | 19,996 | +1.1% | 0.03% | +22.7% |
Q1 2020 | $2,736,000 | -24.6% | 19,770 | -16.4% | 0.02% | -4.3% |
Q4 2019 | $3,629,000 | -4.7% | 23,642 | -10.3% | 0.02% | -8.0% |
Q3 2019 | $3,807,000 | +25.5% | 26,358 | +24.2% | 0.02% | +25.0% |
Q2 2019 | $3,033,000 | +9.0% | 21,223 | +0.7% | 0.02% | +5.3% |
Q1 2019 | $2,783,000 | +30.2% | 21,081 | +1.7% | 0.02% | +18.8% |
Q4 2018 | $2,138,000 | -8.3% | 20,729 | -3.4% | 0.02% | +14.3% |
Q3 2018 | $2,332,000 | +56.6% | 21,461 | +42.2% | 0.01% | +55.6% |
Q2 2018 | $1,489,000 | +14.0% | 15,090 | +13.1% | 0.01% | +12.5% |
Q1 2018 | $1,306,000 | -26.4% | 13,339 | -30.2% | 0.01% | -20.0% |
Q4 2017 | $1,774,000 | +16.4% | 19,108 | +7.5% | 0.01% | +25.0% |
Q3 2017 | $1,524,000 | +0.7% | 17,767 | -0.9% | 0.01% | 0.0% |
Q2 2017 | $1,514,000 | +2.2% | 17,936 | +3.5% | 0.01% | 0.0% |
Q1 2017 | $1,482,000 | +55.5% | 17,324 | +41.4% | 0.01% | +60.0% |
Q4 2016 | $953,000 | +4.8% | 12,249 | +5.6% | 0.01% | 0.0% |
Q3 2016 | $909,000 | -23.0% | 11,599 | -0.8% | 0.01% | -16.7% |
Q2 2016 | $1,181,000 | -2.8% | 11,693 | -8.7% | 0.01% | 0.0% |
Q1 2016 | $1,215,000 | +3.9% | 12,805 | +1.8% | 0.01% | 0.0% |
Q4 2015 | $1,169,000 | +10.4% | 12,582 | +1.3% | 0.01% | +20.0% |
Q3 2015 | $1,059,000 | +15.4% | 12,426 | +15.9% | 0.01% | +25.0% |
Q2 2015 | $918,000 | -1.5% | 10,723 | -2.3% | 0.00% | 0.0% |
Q1 2015 | $932,000 | -8.2% | 10,981 | -7.3% | 0.00% | 0.0% |
Q4 2014 | $1,015,000 | -1.6% | 11,844 | -12.7% | 0.00% | 0.0% |
Q3 2014 | $1,031,000 | +14.4% | 13,568 | +18.5% | 0.00% | 0.0% |
Q2 2014 | $901,000 | -11.8% | 11,450 | -16.0% | 0.00% | 0.0% |
Q1 2014 | $1,022,000 | +108.6% | 13,625 | +114.9% | 0.00% | +100.0% |
Q4 2013 | $490,000 | +13.4% | 6,341 | +1.8% | 0.00% | 0.0% |
Q3 2013 | $432,000 | -84.6% | 6,226 | -85.9% | 0.00% | -84.6% |
Q2 2013 | $2,805,000 | +509.8% | 44,309 | +498.3% | 0.01% | +550.0% |
Q1 2013 | $460,000 | – | 7,406 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |